Keyword: Sanofi Genzyme due diligence
News
08.03.2011
- Genzyme Chief Executive Henri Termeer is set to walk away with nearly $160 million when the sale of his company to French drugmaker Sanofi-Aventis is final - and stands to earn...
News
03.02.2011
- French drugmaker Sanofi-Aventis could announce a deal to buy U.S. biotech Genzyme early next week if final negotiations between the companies go smoothly, Le Figaro reported on...
News
02.02.2011
- France's Sanofi-Aventis has agreed to raise its bid for Genzyme Corp to the low $70s-per-share range, plus a milestone payment based on the performance of an experimental drug, a...
News
01.02.2011
- U.S. biotech Genzyme and French drugmaker Sanofi-Aventis have reached agreement in principle on the terms of a deal under which Sanofi would acquire Genzyme, three sources familiar...